Stay updated on Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial

Sign up to get notified when there's something new on the Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-20T05:54:37.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Standardized the disease name hyphenation to 'Alpha-1 antitrypsin deficiency'.
    Difference
    0.1%
    Check dated 2026-03-30T01:23:19.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    Revision: v3.5.0 is now displayed, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-22T16:12:37.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-07T04:51:41.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now shown, replacing v3.4.1, with no study content changes; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:41:06.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    The page version label was updated from v3.4.0 to v3.4.1. No core content, eligibility criteria, or study data appear to be altered based on the screenshot.
    Difference
    0.1%
    Check dated 2026-02-05T17:19:19.000Z thumbnail image

Stay in the know with updates to Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Phase 1 Study of INBRX-101 in AATD Adults: Clinical Trial page.